Skip to main content
SpringerLink
Log in

Endocannabinoids, “New-Old” Mediators of Stress Homeostasis

  • Chapter
  • First Online:
Stress Challenges and Immunity in Space

Abstract

The endocannabinoid system (ECS) is an old and evolutionarily well preserved neurobiologic system controlling some key elements of organ homeostasis. In contrast to its long biologic history, the scientific record of the ECS is very short. Whereas the occurrence of genes for the endocannabinoid receptors has been described in ancient animals reaching at least as far back as the predecessor of tetrapods (amphibians reptiles, birds, and mammals), modern science has only more recently demonstrated that the ECS is involved in the regulation of a wide range of essential central and peripheral processes which include metabolism and feeding behavior, inflammatory- and anti-inflammatory immunologic reactions, neurobehavioral changes during stress and anxiety and the regulation of central functions such as cognition and memory. One of the most important roles of the ECS lies in the regulation and orchestration of the central and immunologic stress response to aversive and threatening life conditions. There are already data that the ECS is affected in humans during highly aversive conditions of parabolic flights and space flights as well as in other extreme living conditions (e.g. Antarctica). The ECS may therefore have an important function for adaption processes in such aversive conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abdulnour J, Yasari S, Rabasa-Lhoret R, Faraj M, Petrosino S, Piscitelli F, Prud’ Homme D, Di Marzo V (2014) Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study. Obesity (Silver Spring) 22(1):211–216

    Google Scholar 

  • Alarcón-Yaquetto DE, Caballero L, Gonzales GF (2017) Association between plasma N-Acylethanolamides and high hemoglobin concentration in Southern Peruvian highlanders. High Alt Med Biol 18(4):322–329

    Google Scholar 

  • Al Suleimani YM, Al Mahruqi AS (2017) The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant. Eur J Pharmacol 794:209–215

    Google Scholar 

  • Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A (2008) Endocannabinoids and the regulation of bone metabolism. J Neuroendocrinol 20(Suppl 1):69–74

    Article  CAS  PubMed  Google Scholar 

  • Bab IA, Yirmiya R (2010) Depression and bone mass. Ann N Y Acad Sci 1192:170–175

    Article  PubMed  Google Scholar 

  • Baldassarri S, Bertoni A, Bagarotti A, Sarasso C, Zanfa M, Catani MV, Avigliano L, Maccarrone M, Torti M, Sinigaglia F (2008) The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors. J Thromb Haemost 6:1772–1779

    Article  CAS  PubMed  Google Scholar 

  • Basavarajappa BS, Hungund BL (2005) Role of the endocannabinoid system in the development of tolerance to alcohol. Alcohol Alcohol 40:15–24

    Article  CAS  PubMed  Google Scholar 

  • Batkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J, Offertaler L, Mackie K, Rudd MA, Bukoski RD, Kunos G (2004) Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110:1996–2002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Begg M, Mo FM, Offertaler L, Batkai S, Pacher P, Razdan RK, Lovinger DM, Kunos G (2003) G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current. J Biol Chem 278:46188–46194

    Article  CAS  PubMed  Google Scholar 

  • Bo Tan HBB, Rimmerman N, Srinivasan H, Yu YW, Krey JF, Monn MF, Chen JS-C, Hu SS-J, Pickens SR, Walker JM (2006) Targeted lipidomics: discovery of new fatty acyl amides. AAPS J 8(3):E461–E465

    Article  PubMed  PubMed Central  Google Scholar 

  • Bowles NP, Karatsoreos IN, Li X, Vemuri VK, Wood JA, Li Z, Tamashiro KL, Schwartz GJ, Makriyannis AM, Kunos G, Hillard CJ, McEwen BS, Hill MN (2015) A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome. Proc Natl Acad Sci U S A 112(1):285–290

    Google Scholar 

  • Braun A, Engel T, Aguilar-Pimentel JA, Zimmer A, Jakob T, Behrendt H, Mempel M (2011) Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors. Immunobiology 216(4):466–476

    Article  CAS  PubMed  Google Scholar 

  • Brozoski DT, Dean C, Hopp FA, Seagard JL (2005) Uptake blockade of endocannabinoids in the NTS modulates baroreflex-evoked sympathoinhibition. Brain Res 1059:197–202

    Article  CAS  PubMed  Google Scholar 

  • Chen DJ, Gao M, Gao FF, Su QX, Wu J (2017) Brain cannabinoid receptor 2: expression, function and modulation. Acta Pharmacol Sin 38:312–316

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen Y, McCarron RM, Ohara Y, Bembry J, Azzam N, Lenz FA, Shohami E, Mechoulam R, Spatz M (2000) Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Circ Res 87:323–327

    Article  CAS  PubMed  Google Scholar 

  • Chiurchiù V, van der Stelt M, Centonze D, Maccarrone M (2018) The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for other neuroinflammatory diseases. Prog Neurobiol 160:82–100

    Google Scholar 

  • Chouker A, Kaufmann I, Kreth S, Hauer D, Feuerecker M, Thieme D, Vogeser M, Thiel M, Schelling G (2010) Motion sickness, stress and the endocannabinoid system. PLoS One 5:e10752

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • del Carmen García MA-GE, Celuch SM (2003) Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats. Naunyn Schmiedeberg's Arch Pharmacol 368(4):270–276

    Article  CAS  Google Scholar 

  • De Luca R, Mazur K, Kernder A, Suvorava T, Kojda G, Haas HL, Sergeeva OA (2018) Mechanisms of N-oleoyldopamine activation of central histaminergic neurons. Neuropharmacology 143:327–338

    Google Scholar 

  • Di Marzo V, Verrijken A, Hakkarainen A, Petrosino S, Mertens I, Lundbom N, Piscitelli F, Westerbacka J, Soro-Paavonen A, Matias I, Van Gaal L, Taskinen MR (2009) Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. Eur J Endocrinol 161(5):715–722

    Google Scholar 

  • Dotsey E, Ushach I, Pone E, Nakajima R, Jasinskas A, Argueta DA, Dillon A, DiPatrizio N, Davies H, Zlotnik A, Crompton PD, Felgner PL (2017) Transient cannabinoid Receptor 2 blockade during immunization heightens intensity and breadth of antigen-specific antibody responses in young and aged mice. Sci Rep 7:42584

    Google Scholar 

  • Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613

    CAS  PubMed  Google Scholar 

  • Dlugos A, Childs E, Stuhr KL, Hillard CJ, de Wit H (2012) Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology 37:2416–2427

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Duncan M, Millns P, Smart D, Wright JE, Kendall DA, Ralevic V (2004) Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor. Br J Pharmacol 142:509–518

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Durst R, Danenberg H, Gallily R, Mechoulam R, Meir K, Grad E, Beeri R, Pugatsch T, Tarsish E, Lotan C (2007) Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury. Am J Physiol Heart Circ Physiol 293:H3602–H3607

    Article  CAS  PubMed  Google Scholar 

  • Effimia Gkoumassi BGJDMJD, Elzinga CRS, Hasenbosch RE, Meurs H, Nelemans SA, Schmidt M, Zaagsma J (2009) (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells. Naunyn-Schmied Arch Pharmacol 380(1):67–77

    Article  CAS  Google Scholar 

  • Feuerecker M, Hauer D, Toth R, Demetz F, Holzl J, Thiel M, Kaufmann I, Schelling G, Chouker A (2012) Effects of exercise stress on the endocannabinoid system in humans under field conditions. Eur J Appl Physiol 112:2777–2781

    Article  CAS  PubMed  Google Scholar 

  • Ford WR, Honan SA, White R, Hiley CR (2002) Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br J Pharmacol 135:1191–1198

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Freemon FR (1972) Effects of marihuana on sleeping states. JAMA 220:1364–1365

    Article  CAS  PubMed  Google Scholar 

  • Gatta-Cherifi B, Matias I, Vallée M, Tabarin A, Marsicano G, Piazza PV, Cota D (2012) Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. Int J Obes (Lond) 36(6):880–885

    Google Scholar 

  • Gauthier KM, Baewer DV, Hittner S, Hillard CJ, Nithipatikom K, Reddy DS, Falck JR, Campbell WB (2005) Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. Am J Physiol Heart Circ Physiol 288:H1344–H1351

    Article  CAS  PubMed  Google Scholar 

  • Godlewski G, Offertaler L, Osei-Hyiaman D, Mo FM, Harvey-White J, Liu J, Davis MI, Zhang L, Razdan RK, Milman G, Pacher P, Mukhopadhyay P, Lovinger DM, Kunos G (2009) The endogenous brain constituent N-arachidonoyl L-serine is an activator of large conductance Ca2+-activated K+ channels. J Pharmacol Exp Ther 328:351–361

    Article  CAS  PubMed  Google Scholar 

  • Grabiec U, Dehghani F (2017) N-Arachidonoyl dopamine: a novel endocannabinoid and endovanilloid with widespread physiological and pharmacological activities. Cannabis Cannabinoid Res 2(1):183–196. https://doi.org/10.1089/can

  • Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, de Wit H, Hillard CJ, Van Cauter E (2016) Sleep restriction enhances the daily rhythm of circulating levels of endocannabinoid 2-arachidonoylglycerol. Sleep 39(3):653–664

    Google Scholar 

  • Hauer D, Schelling G, Gola H, Campolongo P, Morath J, Roozendaal B, Hamuni G, Karabatsiakis A, Atsak P, Vogeser M, Kolassa IT (2013) Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS One 8:e62741

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hauer D, Weis F, Papassotiropoulos A, Schmoeckel M, Lieke J, Kaufmann I, Kirchhoff F, Vogeser M, Roozendaal B, Briegel J, de Quervain D, Schelling G (2010) Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Crit Care Med 30:7

    Google Scholar 

  • Hayase T (2007) Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs. BMC Neurosci 8:76

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hayase T (2008) Nicotine (NC)-induced “depressive” behavioral symptoms and effects of antidepressants including cannabinoids (CBs). J Toxicol Sci 33:555–564

    Article  CAS  PubMed  Google Scholar 

  • Herrera-Solis A, Vasquez KG, Prospero-Garcia O (2010) Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. Pharmacol Biochem Behav 95:106–112

    Article  CAS  PubMed  Google Scholar 

  • Hill MN, McEwen BS (2009a) Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuro-Psychopharmacol Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2009.11.001

  • Hill MN, McEwen BS (2009b) Endocannabinoids: the silent partner of glucocorticoids in the synapse. Proc Natl Acad Sci U S A 106:4579–4580

    Article  PubMed  PubMed Central  Google Scholar 

  • Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ (2009) Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 34:1257–1262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, Hillard CJ, Yehuda R (2013) Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology 38:2952–2961

    Article  CAS  PubMed  Google Scholar 

  • Hillard CJ. (2018) Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacology:155–172

    Google Scholar 

  • Ho WS, Barrett DA, Randall MD (2008) ‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br J Pharmacol 155:837–846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Howlett AC (2005) Cannabinoid receptor signaling. Handb Exp Pharmacol 168:53–79

    Article  CAS  Google Scholar 

  • Im DS (2009) New intercellular lipid mediators and their GPCRs: an update. Prostaglandins Other Lipid Mediat 89:53–56

    Article  CAS  PubMed  Google Scholar 

  • Jhaveri MD, Richardson D, Kendall DA, Barrett DA, Chapman V (2006) Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J Neurosci 26:13318–13327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Joseph J, Niggemann B, Zaenker KS, Entschladen F (2004) Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother 53:723–728

    Article  CAS  PubMed  Google Scholar 

  • Jones EK, Kirkham TC (2012) Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats. Br J Pharmacol 166(6):1815–1821

    Google Scholar 

  • Jumpertz R, Wiesner T, Bluher M, Engeli S, Batkai S, Wirtz H, Bosse-Henck A, Stumvoll M (2010) Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea-specific role of oleoylethanolamide. Exp Clin Endocrinol Diabetes 118:591–595

    Article  CAS  PubMed  Google Scholar 

  • Jyotaki M, Shigemura N, Ninomiya Y (2010) Modulation of sweet taste sensitivity by orexigenic and anorexigenic factors. Endocr J 57:467–475

    Article  CAS  PubMed  Google Scholar 

  • Karsak M, Cohen-Solal M, Freudenberg J, Ostertag A, Morieux C, Kornak U, Essig J, Erxlebe E, Bab I, Kubisch C, de Vernejoul MC, Zimmer A (2005) Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet 14:3389–3396

    Article  CAS  PubMed  Google Scholar 

  • Kaufmann I, Hauer D, Huge V, Vogeser M, Campolongo P, Chouker A, Thiel M, Schelling G (2009) Enhanced anandamide plasma levels in patients with complex regional pain syndrome following traumatic injury: a preliminary report. Eur Surg Res 43:325–329

    Article  CAS  PubMed  Google Scholar 

  • Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H (2003) The cannabinoid system and immune modulation. J Leukoc Biol 74:486–496

    Article  CAS  PubMed  Google Scholar 

  • Knight JM, Szabo A, Zhao S, Lyness JM, Sahler OJ, Liesveld JL, Sander T, Rizzo JD, Hillard CJ, Moynihan JA (2015) Circulating endocannabinoids during hematopoietic stem cell transplantation: a pilot study. Neurobiol Stress 2:44–50

    Google Scholar 

  • Koethe D, Schreiber D, Giuffrida A, Mauss C, Faulhaber J, Heydenreich B, Hellmich M, Graf R, Klosterkotter J, Piomelli D, Leweke FM (2009) Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid. J Neural Transm 116:301–305

    Google Scholar 

  • Konieczny J, Przegalinski E, Pokorski M (2009) N-Oleoyl-dopamine decreases muscle rigidity induced by reserpine in rats. Int J Immunopathol Pharmacol 22:21–28

    Article  CAS  PubMed  Google Scholar 

  • Kozlowska H, Baranowska M, Schlicker E, Kozlowski M, Laudanski J, Malinowska B (2008) Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. Br J Pharmacol 155:1034–1042

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Krumbholz A, Anielski P, Reisch N, Schelling G, Thieme D (2013) Diagnostic value of concentration profiles of glucocorticosteroids and endocannabinoids in hair. Ther Drug Monit 35:600–607

    CAS  PubMed  Google Scholar 

  • Krylatov AV, Maslov LN, Ermakov S, Lasukova OV, Barzakh EI, Crawford D, Pertwee RG (2007) Significance of cardiac cannabinoid receptors in regulation of cardiac rhythm, myocardial contractility, and electrophysiologic processes in heart. Izv Akad Nauk Ser Biol 1:35–44

    Google Scholar 

  • Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283:401–404

    Article  CAS  PubMed  Google Scholar 

  • Maccarrone M, Pauselli R, Di Rienzo M, Finazzi-Agro A (2002) Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. Biochem J 366:137–144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A (2000) Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem 275:31938–31945

    Article  CAS  PubMed  Google Scholar 

  • Mach F, Steffens S (2008) The role of the endocannabinoid system in atherosclerosis. J Neuroendocrinol 20(Suppl 1):53–57

    Article  CAS  PubMed  Google Scholar 

  • Maeda N, Osanai T, Kushibiki M, Fujiwara T, Tamura Y, Oowada S, Higuma T, Sasaki S, Yokoyama J, Yoshimachi F, Matsunaga T, Hanada H, Okumura K (2009) Increased serum anandamide level at ruptured plaque site in patients with acute myocardial infarction. Fundam Clin Pharmacol 23:351–357

    Article  CAS  PubMed  Google Scholar 

  • Mallet PEB, Beninger RJ (1996) The endogenous cannabinoid receptor agonist anandamide impairs memory in rats. Behav Pharmacol 7:261–275

    Article  Google Scholar 

  • Mechoulam R, Gaoni Y (1965) A total synthesis of Dl-delta-1-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87:3273–3275

    Article  CAS  PubMed  Google Scholar 

  • Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z (1997) Anandamide may mediate sleep induction. Nature 389:25–26

    Article  CAS  PubMed  Google Scholar 

  • Monteleone AM, Di Marzo V, Monteleone P, Dalle Grave R, Aveta T, Ghoch ME, Piscitelli F, Volpe U, Calugi S, Maj M (2016) Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity. Eur J Nutr 55(4):1799–1805

    Google Scholar 

  • Movahed P, Evilevitch V, Andersson TL, Jonsson BA, Wollmer P, Zygmunt PM, Hogestatt ED (2005) Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. Br J Pharmacol 146:171–179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mulawa EA, Kirkwood JS, Wolfe LM, Wojda SJ, Prenni JE, Florant GL, Donahue SW (2018) Seasonal changes in endocannabinoid concentrations between active and hibernating marmots (marmota flaviventris). J Biol Rhythms 33(4):388–401

    Google Scholar 

  • Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, Martinez-Gonzalez D, Drucker-Colin R, Prospero-Garcia O (1998) Anandamide modulates sleep and memory in rats. Brain Res 812:270–274

    Article  CAS  PubMed  Google Scholar 

  • Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, Potenza MN, Bailey CR, Lin SF, Najafzadeh S, Ropchan J, Henry S, Corsi-Travali S, Carson RE, Huang Y (2013) Elevated brain cannabinoid CB receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry 18(9):1034–1040

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Niederhoffer N, Szabo B (1999) Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol 126:457–466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • O’Sullivan SE, Kendall DA (2009) Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology 215(8):611–616

    Article  CAS  PubMed  Google Scholar 

  • Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 103:696–701

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Offertaler L, Mo FM, Batkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G (2003) Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63:699–705

    Article  CAS  PubMed  Google Scholar 

  • Olatinsu AO, Sihag J, Jones PJH (2017) Relationship between circulating fatty acids and fatty acid ethanolamide levels after a single 2-h dietary fat feeding in male Sprague-dawley rats: elevated levels of oleoylethanolamide, palmitoylethanolamide, linoleoylethanolamide, arachidonoylethanolamide and docosahexanoylethanolamide after a single 2 h dietary fat feeding in male Sprague Dawley rats. Lipids 52(11):901–906

    Google Scholar 

  • Pacher P, Mechoulam R (2011) Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 50(2):193–211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389–462

    Article  CAS  PubMed  Google Scholar 

  • Pandey R, Mousawy K, Nagarkatti M, Nagarkatti P (2009) Endocannabinoids and immune regulation. Pharmacol Res 60:85–92

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R, Alexandrovich A, Shohami E (2006) The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 22(2):257–264

    Google Scholar 

  • Parmar N, Ho WS (2010) N-Arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels. Br J Pharmacol 160:594–603

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pertwee RG (2001) Cannabinoid receptors and pain. Prog Neurobiol 63:569–611

    Article  CAS  PubMed  Google Scholar 

  • Pertwee RG, Ross RA (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66:101–121

    Article  CAS  PubMed  Google Scholar 

  • Pfitzer T, Niederhoffer N, Szabo B (2005) Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system. Naunyn Schmiedeberg’s Arch Pharmacol 371:9–17

    Article  CAS  Google Scholar 

  • Piro JR, Suidan GL, Quan J, Pi Y, O’Neill SM, Ilardi M, Pozdnyakov N, Lanz TA, Xi H, Bell RD, Samad TA (2018) Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury. J Neuroinflammation 15(1):142

    Google Scholar 

  • Pisanti S, Borselli C, Oliviero O, Laezza C, Gazzerro P, Bifulco M (2007) Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. J Cell Physiol 211:495–503

    Article  CAS  PubMed  Google Scholar 

  • Przegalinski E, Filip M, Zajac D, Pokorski M (2006) N-Oleoyl-dopamine increases locomotor activity in the rat. Int J Immunopathol Pharmacol 19:897–904

    Google Scholar 

  • Randall MD, Kendall DA, O’Sullivan S (2004) The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol 142:20–26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sah P (2002) Never fear, cannabinoids are here. Nature 418:488–489

    Article  CAS  PubMed  Google Scholar 

  • Sancho R, Macho A, de La Vega L, Calzado MA, Fiebich BL, Appendino G, Munoz E (2004) Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways. J Immunol 172:2341–2351

    Article  CAS  PubMed  Google Scholar 

  • Schmidt A, Brune K, Hinz B (2006) Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. Biomed Chromatogr 20:336–342

    Article  CAS  PubMed  Google Scholar 

  • Schroeder C, Batkai S, Engeli S, Tank J, Diedrich A, Luft FC, Jordan J (2009) Circulating endocannabinoid concentrations during orthostatic stress. Clin Auton Res 19:343–346

    Article  PubMed  Google Scholar 

  • Schloss MJ, Horckmans M, Guillamat-Prats R, Hering D, Lauer E, Lenglet S, Weber C, Thomas A, Steffens S (2019) 2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction. Cardiovasc Res 115(3):602–613

    Google Scholar 

  • Selye H (1936) Syndrome produced by diverse nocuous agents. Nature 138:32

    Article  Google Scholar 

  • Sergeeva OA, De Luca R, Mazur K, Chepkova AN, Haas HL, Bauer A (2017) N-oleoyldopamine modulates activity of midbrain dopaminergic neurons through multiple mechanisms. Neuropharmacology 119:111–122

    Google Scholar 

  • Sido JM, Nagarkatti PS, Nagarkatti M (2016) Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed-type hypersensitivity. Eur J Immunol 46:1472–1479

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Singh P, Sharma P, Nakade UP, Sharma A, Gari M, Choudhury S, Shukla A, Garg SK (2018) Endocannabinoid-mediated modulation of Gq protein-coupled receptor mediates vascular hyporeactivity to nor-adrenaline during polymicrobial sepsis. Pharmacol Rep 70(6):1150–1157

    Google Scholar 

  • Sophocleous A, Marino S, Kabir D, Ralston SH, Idris AI (2017) Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition. Aging Cell 16(5):1051–1061

    Google Scholar 

  • Steiner MA, Wotjak CT (2008) Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog Brain Res 170:397–432

    Article  CAS  PubMed  Google Scholar 

  • Stephen V, Mahler KSS, Berridge KC (2007) Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances ‘liking’ of a sweet reward. Neuropsychopharmacology 32(11):2267–2278

    Article  CAS  Google Scholar 

  • Steudte S, Kirschbaum C, Gao W, Alexander N, Schonfeld S, Hoyer J, Stalder T (2013) Hair cortisol as a biomarker of traumatization in healthy individuals and posttraumatic stress disorder patients. Biol Psychiatry 74:639–646

    Article  CAS  PubMed  Google Scholar 

  • Sticht MA, Limebeer CL, Rafla BR, Abdullah RA, Poklis JL, Ho W, Niphakis MJ, Cravatt BF, Sharkey KA, Lichtman AH, Parker LA (2016) Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex. Neuropharmacology 102:92–102

    Google Scholar 

  • Storozhuk MV, Zholos AV (2018) TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling. Curr Neuropharmacol 16:137–150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Strewe C, Feuerecker M, Nichiporuk I, Kaufmann I, Hauer D, Morukov B, Schelling G, Chouker A (2012) Effects of parabolic flight and spaceflight on the endocannabinoid system in humans. Rev Neurosci 23:673–680

    Article  CAS  PubMed  Google Scholar 

  • Strewe C, Thieme D, Dangoisse C, Fiedel B, van den Berg F, Bauer H, Salam AP, Gössmann-Lang P, Campolongo P, Moser D, Quintens R, Moreels M, Baatout S, Kohlberg E, Schelling G, Choukèr A, Feuerecker M (2018) Modulations of neuroendocrine stress responses during confinement in antarctica and the role of hypobaric hypoxia. Front Physiol 9:1647

    Google Scholar 

  • Strollo F (1999) Hormonal changes in humans during spaceflight. Adv Space Biol Med 7:99–129

    Article  CAS  PubMed  Google Scholar 

  • Su JY, Vo AC (2007) 2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling. Eur J Pharmacol 559:189–195

    Article  CAS  PubMed  Google Scholar 

  • Sun Y, Alexander SP, Garle MJ, Gibson CL, Hewitt K, Murphy SP, Kendall DA, Bennett AJ (2007) Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. Br J Pharmacol 152:734–743

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sunano S, Watanabe H, Tanaka S, Sekiguchi F, Shimamura K (1999) Endothelium-derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive rats. Br J Pharmacol 126:709–716

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tanasescu R, Constantinescu CS (2010) Cannabinoids and the immune system: an overview. Immunobiology 215:588–597

    Article  CAS  PubMed  Google Scholar 

  • Tasker J (2004) Endogenous cannabinoids take the edge off neuroendocrine responses to stress. Endocrinology 145:5429–5430

    Article  CAS  PubMed  Google Scholar 

  • Terrazzino S, Berto F, Dalle Carbonare M, Fabris M, Guiotto A, Bernardini D, Leon A (2004) Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. FASEB J 18:1580–1582

    Article  CAS  PubMed  Google Scholar 

  • Thieme U, Schelling G, Hauer D, Greif R, Dame T, Laubender RP, Bernhard W, Thieme D, Campolongo P, Theiler L (2014) Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. Drug Test Anal 6:17–23

    Google Scholar 

  • Tsuboi K, Uyama T, Okamoto Y, Ueda N (2018) Endocannabinoids and related N-acylethanolamines: biological activities and metabolism. Inflamm Regen. 38:28

    Google Scholar 

  • Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ (2010) Endocannabinoid signalling: has it got rhythm? Br J Pharmacol 160:530–543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Venderova K, Brown TM, Brotchie JM (2005) Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. Exp Neurol 194:284–287

    Article  CAS  PubMed  Google Scholar 

  • Vogeser M, Schelling G (2007) Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples. Clin Chem Lab Med 45:1023–1025

    CAS  PubMed  Google Scholar 

  • Vogeser M, Hauer D, Christina Azad S, Huber E, Storr M, Schelling G (2006) Release of anandamide from blood cells. Clin Chem Lab Med 44:488–491

    CAS  PubMed  Google Scholar 

  • Vuong LA, Mitchell VA, Vaughan CW (2008) Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology 54:189–193

    Article  CAS  PubMed  Google Scholar 

  • Wagner JA, Abesser M, Karcher J, Laser M, Kunos G (2005) Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts. J Cardiovasc Pharmacol 46:348–355

    Article  CAS  PubMed  Google Scholar 

  • Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G (1997) Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390:518–521

    Article  CAS  PubMed  Google Scholar 

  • Wagner JA, Hu K, Bauersachs J, Karcher J, Wiesler M, Goparaju SK, Kunos G, Ertl G (2001) Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J Am Coll Cardiol 38:2048–2054

    Article  CAS  PubMed  Google Scholar 

  • Weis F, Beiras-Fernandez A, Sodian R, Kaczmarek I, Reichart B, Beiras A, Schelling G, Kreth S (2010) Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. J Mol Cell Cardiol 48:1187–1193

    Article  CAS  PubMed  Google Scholar 

  • Wheal AJ, Alexander SP, Randall MD (2010) Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity. Br J Pharmacol 160:701–711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • White R, Hiley CR (1998) The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. Br J Pharmacol 125:533–541

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wilker S, Pfeiffer A, Elbert T, Ovuga E, Karabatsiakis A, Krumbholz A, Thieme D, Schelling G, Kolassa IT (2016) Endocannabinoid concentrations in hair are associated with PTSD symptom severity. Psychoneuroendocrinology 67:198–206

    Article  CAS  PubMed  Google Scholar 

  • Yi B, Nichiporuk I, Nicolas M, Schneider S, Feuerecker M, Vassilieva G, Thieme D, Schelling G, Choukèr A (2016) Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors. Prog Neuropsychopharmacol Biol Psychiatry 67:92–97

    Google Scholar 

  • Zona LC, Fry BR, LaLonde JA, Cromwell HC (2017) Effects of anandamide administration on components of reward processing during free choice. Pharmacol Biochem Behav 158:14–21

    Google Scholar 

  • Zhang X, Maor Y, Wang JF, Kunos G, Groopman JE (2010) Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator. Br J Pharmacol 160:1583–1594

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anaesthesiology, Hospital of the Ludwig-Maximilians-University (LMU), Munich, Germany

    Daniela Hauer & Gustav Schelling

  2. Department of Cardiac Surgery, Semmelweis University, Budapest, Hungary

    Roland Toth

Authors
  1. Daniela Hauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roland Toth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gustav Schelling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gustav Schelling .

Editor information

Editors and Affiliations

  1. Laboratory of Translational Research Stress and Immunity Department of Anaesthesiology, Hospital of the University of Munich (LMU), Munich, Germany

    Alexander Choukèr

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hauer, D., Toth, R., Schelling, G. (2020). Endocannabinoids, “New-Old” Mediators of Stress Homeostasis. In: Choukèr, A. (eds) Stress Challenges and Immunity in Space. Springer, Cham. https://doi.org/10.1007/978-3-030-16996-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16996-1_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16995-4

  • Online ISBN: 978-3-030-16996-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation